Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Lister

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Gastroenterology & Hepatology|April 7, 2025
Nonendoscopic Testing for Esophageal Precancer in an At-Risk PopulationDan Lister
Bioinformatics (Oxford, England)|February 1, 2011
SHRiMP2: sensitive yet practical SHort Read MappingMatei David, Misko Dzamba, Dan Lister, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Real-World Clinical Utility of a Methylated DNA Biomarker Assay on Samples Collected with a Swallowable Capsule-Balloon for Detection of Barrett's Esophagus (BE)Dan Lister, Andy Fine, Shail Maheshwari, et al.
The American Journal of Gastroenterology|January 8, 2026
The Utility of MUC2 and CDX2 Expression in the Diagnosis of Barrett's Esophagus: A Community-based Study of Wide-Area Transepithelial Sampling and Forceps BiopsiesNicholas J Shaheen, F Scott Corbett, Mendel E Singer, et al.
Gastrointestinal Endoscopy|July 22, 2018
Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trialReginald Bell, John Lipham, Brian Louie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2019
Magnetic Sphincter Augmentation Superior to Proton Pump Inhibitors for Regurgitation in a 1-Year Randomized TrialReginald Bell, John Lipham, Brian E Louie, et al.
Gastrointestinal Endoscopy|February 3, 2020
Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panelAndrew J Gawron, Reginald Bell, Barham K Abu Dayyeh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Gastroenterology & Hepatology|April 7, 2025
Nonendoscopic Testing for Esophageal Precancer in an At-Risk PopulationDan Lister
Bioinformatics (Oxford, England)|February 1, 2011
SHRiMP2: sensitive yet practical SHort Read MappingMatei David, Misko Dzamba, Dan Lister, et al.
Medicina (Kaunas, Lithuania)|January 8, 2025
Real-World Clinical Utility of a Methylated DNA Biomarker Assay on Samples Collected with a Swallowable Capsule-Balloon for Detection of Barrett's Esophagus (BE)Dan Lister, Andy Fine, Shail Maheshwari, et al.
The American Journal of Gastroenterology|January 8, 2026
The Utility of MUC2 and CDX2 Expression in the Diagnosis of Barrett's Esophagus: A Community-based Study of Wide-Area Transepithelial Sampling and Forceps BiopsiesNicholas J Shaheen, F Scott Corbett, Mendel E Singer, et al.
Gastrointestinal Endoscopy|July 22, 2018
Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trialReginald Bell, John Lipham, Brian Louie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2019
Magnetic Sphincter Augmentation Superior to Proton Pump Inhibitors for Regurgitation in a 1-Year Randomized TrialReginald Bell, John Lipham, Brian E Louie, et al.
Gastrointestinal Endoscopy|February 3, 2020
Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panelAndrew J Gawron, Reginald Bell, Barham K Abu Dayyeh, et al.
Pageof 1